Use of Risk Factors To Select Adjuvant Therapy Versus Surveillance for Testicular Nonseminoma and Seminoma Germ Cell Tumors

Gedske Daugaard*, Jakob Lauritsen, Mikkel Bandak, Mads Agerbæk, Anne B Als, Lars Dysager, Birgitte G Toft, Birte Engvad, Daniel M Berney, Thomas Wagner

*Corresponding author for this work
1 Citation (Scopus)

Abstract

New risk factors associated with relapse of stage I testicular cancer have been identified. These new factors reflect the risk of recurrence much better than previous parameters and can be used to assess the possible effect of adjuvant chemotherapy.

Original languageEnglish
JournalEuropean Urology Focus
Volume10
Issue number3
Pages (from-to)359-360
Number of pages2
ISSN2405-4569
DOIs
Publication statusPublished - May 2024

Keywords

  • Chemotherapy, Adjuvant
  • Humans
  • Male
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Neoplasms, Germ Cell and Embryonal/pathology
  • Risk Factors
  • Seminoma/pathology
  • Testicular Neoplasms/pathology
  • Watchful Waiting

Fingerprint

Dive into the research topics of 'Use of Risk Factors To Select Adjuvant Therapy Versus Surveillance for Testicular Nonseminoma and Seminoma Germ Cell Tumors'. Together they form a unique fingerprint.

Cite this